The drugs were highly safe and effective at reducing the severity of COVID-19 infections before the latest variants, especially among unvaccinated people.
Before resistance developed, monoclonal antibodies were highly effective in preventing severe COVID-19
Published in COVID-19
More from COVID-19More posts in COVID-19 »
- Global, US data show high antibiotic use, rise in resistant infections during COVID
- US respiratory virus levels continue to decline as officials track shift in SARS-CoV-2 proportions
- Study reveals promising results for abatacept for severe COVID
- Long-COVID patients more likely to report psychiatric symptoms, cost barriers to therapy